Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S D Kivlighn

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Clinical and Experimental Pharmacology & Physiology|June 1, 1990
Antidiuretic effects of neurotensin in chloralose anaesthetized dogsS D Kivlighn, B S Jandhyala
Expert Opinion on Investigational Drugs|July 5, 2005
Emerging concepts in cardiovascular disease: should elevated serum uric acid be considered a risk factor?D J Dzielak, S D Kivlighn
Expert Opinion on Investigational Drugs|July 2, 2005
The role of the renin angiotensin system in chronic renal diseaseS D Kivlighn, D J Dzielak
Federation Proceedings|February 1, 1987
Antagonism by methysergide of neurogenic vasoconstriction in the dog forelimbB S Jandhyala, S D Kivlighn
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1985
Studies on the role of intracellular sodium and calcium in the centrally mediated pressor effects of CSF [Na+], ouabain and angiotensin II in anesthetized dogsB S Jandhyala, G Hom, S D Kivlighn
Kidney International|January 1, 1994
Effects of BQ-123 on renal function and acute cyclosporine-induced renal dysfunctionS D Kivlighn, R A Gabel, P K Siegl
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1984
Characterization of the neurogenic vasodilatation elicited by central dopamine receptor stimulation with pergolideM F Lokhandwala, S D Kivlighn, B S Jandhyala
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|July 1, 1995
Pharmacology of losartan, an angiotensin II receptor antagonist, in animal models of hypertensionP K Siegl, S D Kivlighn, T P Broten
Journal of Pharmacological and Toxicological Methods|December 1, 1996
A new method of measuring renal function in conscious rats without the use of radioisotopesR A Gabel, R A Ranaei, S D Kivlighn
Kidney International|July 2, 1998
Role of endothelin and nitric oxide imbalance in the pathogenesis of hypoxia-induced arterial hypertensionZ Ni, S Bemanian, S D Kivlighn, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Clinical and Experimental Pharmacology & Physiology|June 1, 1990
Antidiuretic effects of neurotensin in chloralose anaesthetized dogsS D Kivlighn, B S Jandhyala
Expert Opinion on Investigational Drugs|July 5, 2005
Emerging concepts in cardiovascular disease: should elevated serum uric acid be considered a risk factor?D J Dzielak, S D Kivlighn
Expert Opinion on Investigational Drugs|July 2, 2005
The role of the renin angiotensin system in chronic renal diseaseS D Kivlighn, D J Dzielak
Federation Proceedings|February 1, 1987
Antagonism by methysergide of neurogenic vasoconstriction in the dog forelimbB S Jandhyala, S D Kivlighn
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1985
Studies on the role of intracellular sodium and calcium in the centrally mediated pressor effects of CSF [Na+], ouabain and angiotensin II in anesthetized dogsB S Jandhyala, G Hom, S D Kivlighn
Kidney International|January 1, 1994
Effects of BQ-123 on renal function and acute cyclosporine-induced renal dysfunctionS D Kivlighn, R A Gabel, P K Siegl
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1984
Characterization of the neurogenic vasodilatation elicited by central dopamine receptor stimulation with pergolideM F Lokhandwala, S D Kivlighn, B S Jandhyala
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|July 1, 1995
Pharmacology of losartan, an angiotensin II receptor antagonist, in animal models of hypertensionP K Siegl, S D Kivlighn, T P Broten
Journal of Pharmacological and Toxicological Methods|December 1, 1996
A new method of measuring renal function in conscious rats without the use of radioisotopesR A Gabel, R A Ranaei, S D Kivlighn
Kidney International|July 2, 1998
Role of endothelin and nitric oxide imbalance in the pathogenesis of hypoxia-induced arterial hypertensionZ Ni, S Bemanian, S D Kivlighn, et al.
Pageof 4